New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-a) treatment of human cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 1, doi. 10.1007/s00262-004-0549-1
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 1
Results: 10
1
2
Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 25, doi. 10.1007/s00262-004-0562-4
- By:
- Publication type:
- Article
3
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 44, doi. 10.1007/s00262-004-0567-z
- By:
- Publication type:
- Article
4
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 51, doi. 10.1007/s00262-004-0569-x
- By:
- Publication type:
- Article
5
Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 11, doi. 10.1007/s00262-004-0572-2
- By:
- Publication type:
- Article
6
Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 67, doi. 10.1007/s00262-004-0571-3
- By:
- Publication type:
- Article
7
Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 87, doi. 10.1007/s00262-004-0555-3
- By:
- Publication type:
- Article
8
Large intestine intraepithelial lymphocytes fromApc+/+ andApc+/Minmice and their modulation by indigestible carbohydrates: the IL-15/IL-15Ra complex and CD4<sup>+</sup>CD25<sup>+</sup> T cells are the main targets.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 78, doi. 10.1007/s00262-004-0543-7
- By:
- Publication type:
- Article
9
Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 61, doi. 10.1007/s00262-004-0550-8
- By:
- Publication type:
- Article
10
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 37, doi. 10.1007/s00262-004-0574-0
- By:
- Publication type:
- Article